Table 1.
Study Schedule and Outcome Measures.
| Screening | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Visit → | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| Week | ←━ ━ ━1st week━ ━ ━→ | ←━ ━ ━2nd week━ ━ ━→ | |||||||||
| Informed consent | ✓ | ||||||||||
| Demographic characteristics | ✓ | ||||||||||
| FAACT | ✓ | ✓ | ✓ | ||||||||
| EORTC QLQ-C30 | ✓ | ✓ | ✓ | ||||||||
| Anorexia VAS | ✓ | ✓ | ✓ | ||||||||
| Blood test | ✓ | ✓ | |||||||||
| Inclusion/exclusion decision | ✓ | ||||||||||
| Random allocation | ✓ | ||||||||||
| Moxibustion treatment | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
| Safety assessment | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
Abbreviations: FAACT, Functional Assessment of Anorexia/Cachexia Therapy; EORTC QLQ-C30, European Organization for Research and Treatment of Cancer 30-item core quality of life.